Eaton Vance Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $312M | Sell |
|
|||||
|
2022
Q2 | $399M | Sell |
|
|||||
|
2022
Q1 | $420M | Buy |
|
|||||
|
2021
Q4 | $310M | Buy |
|
|||||
|
2021
Q3 | $180M | Buy |
|
|||||
|
2021
Q2 | $168M | Buy |
|
|||||
|
2021
Q1 | $155M | Sell |
|
|||||
|
2020
Q4 | $167M | Sell |
|
|||||
|
2020
Q3 | $169M | Sell |
|
|||||
|
2020
Q2 | $156M | Sell |
|
|||||
|
2020
Q1 | $156M | Sell |
|
|||||
|
2019
Q4 | $198M | Sell |
|
|||||
|
2019
Q3 | $214M | Buy |
|
|||||
|
2019
Q2 | $205M | Buy |
|
|||||
|
2019
Q1 | $197M | Sell |
|
|||||
|
2018
Q4 | $215M | Sell |
|
|||||
|
2018
Q3 | $300M | Sell |
|
|||||
|
2018
Q2 | $311M | Sell |
|
|||||
|
2018
Q1 | $620M | Buy |
|
|||||
|
2017
Q4 | $314M | Buy |
|
|||||
|
2017
Q3 | $302M | Sell |
|
|||||
|
2017
Q2 | $296M | Sell |
|
|||||
|
2017
Q1 | $391M | Sell |
|
|||||
|
2016
Q4 | $409M | Buy |
|
|||||
|
2016
Q3 | $273M | Sell |
|
|||||
|
2016
Q2 | $339M | Buy |
|
|||||
|
2016
Q1 | $112M | Sell |
|
|||||
|
2015
Q4 | $128M | Buy |
|
|||||
|
2015
Q3 | $124M | Buy |
|
|||||
|
2015
Q2 | $119M | Sell |
|
|||||
|
2015
Q1 | $190M | Buy |
|
|||||
|
2014
Q4 | $106M | Sell |
|
|||||
|
2014
Q3 | $160M | Sell |
|
|||||
|
2014
Q2 | $364M | Sell |
|
|||||
|
2014
Q1 | $439M | Sell |
|
|||||
|
2013
Q4 | $514M | Sell |
|
|||||
|
2013
Q3 | $581M | Sell |
|
|||||
|
2013
Q2 | $591M | Buy |
|